Bio-Ved Pharmaceutical Inc is categorized under Biological Research in San Jose, CA and active since 1994.
Bio-Ved Pharmaceutical Inc was established in 1994, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Dr Deepa Chitre at the company’s single location by writing to 1929 Otoole Way, San Jose, California CA 95131 or by phoning (408) 432-4020. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bio-Ved Pharmaceutical Inc |
| Contact Person: | Dr Deepa Chitre |
| Address: | 1929 Otoole Way, San Jose, California 95131 |
| Phone Number: | (408) 432-4020 |
| Website Address: | myartrex.com |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Research |
| SIC Code: | 8731 |
| NAICS Code: | 4242101 |
| Share This Business: |
Bio-Ved Pharmaceutical Inc was started in 1994 to provide professional Biological Research under the SIC code 8731 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Dr Deepa Chitre for inquiries that concern Bio-Ved Pharmaceutical Inc by calling the company number (408) 432-4020, as your correspondence is most welcome. Additionally, the physical location of the single location of Bio-Ved Pharmaceutical Inc can be found at the coordinates 37.38502,-121.90653 as well as the street address 1929 Otoole Way in San Jose, California 95131.
For its online presence, you may visit Bio-Ved Pharmaceutical Inc’s website at myartrex.com and engage with its social media outlets through on Twitter and on Facebook.